shutterstock_1983054248_jhvephoto
JHVEphoto / Shutterstock.com
8 September 2022AmericasMuireann Bolger

Generic maker urges review of $235m skinny label decision

A split Federal Circuit revived a 2017 jury verdict that Teva had infringed GSK drug | Israeli pharma firm warns of threat to availability of low-cost generic medicines.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Americas
14 July 2022   Generics giant’s petition cites the cost of medicine and first-principles of innovation.

More on this story

Big Pharma
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Americas
14 July 2022   Generics giant’s petition cites the cost of medicine and first-principles of innovation.

More on this story

Big Pharma
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Americas
14 July 2022   Generics giant’s petition cites the cost of medicine and first-principles of innovation.